This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
and you are
over 18
years old
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The main objective of this trial is to test the efficacy and safety of carboplatin chemotherapy and involved node radiotherapy in patients with stage IIA/B seminoma.

Provided treatments

  • Drug: Carboplatin
  • Radiation: Involved node RT

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01593241. The sponsor of the trial is Swiss group for clinical cancer research and it is looking for 115 volunteers for the current phase.
Official trial title:
Carboplatin Chemotherapy and Involved Node Radiotherapy in Stage IIA/B Seminoma